louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT06728813: Eat-Lancet Index and Sustainable Eating Across Professions
Official title: Assessing the Link Between the Eat-Lancet Index and Sustainable Eating Practices Across Occupational Groups
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Working Adults
Keywords: Sustainability
occupation
healthy eating
Lead sponsor: Ankara Yildirim Beyazıt University
Sponsor class: OTHER
First posted: 2024-12-11
Enrollment: 2705
Sex: ALL
Minimum age (years): 19
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Community sample in Türkiye

Brief summary: This study aims to evaluate the relationship between the EAT-Lancet Index of occupational groups and sustainable nutrition behaviors. The study included 2,705 individuals aged 19-65 working in various occupations, using dietary assessment tools and the ehaviors Scale Towards Sustainable Nutrition (BSSN), and were analyzed with SPSS 24.

Detailed description: The study included 2,705 individuals aged 19-65 working in various occupations. Data were collected using a demographic structure survey and the Behaviors Scale Towards Sustainable Nutrition (BSSN). A food consumption frequency survey was administered to calculate the EAT-Lancet Index. Occupations were classified into five groups according to the International Standard Classification of Occupations (ISCO)-88: Groups 1-2, 3-4, 5-8, 6-7, and 9-10. Additionally, occupational skill levels were categorized into four levels (1 being the lowest and 4 the highest) based on ISCO-88. Statistical analysis was performed using SPSS version 24.

Eligibility criteria: Inclusion Criteria:

* Patients aged 19 to 65 years

Exclusion Criteria:

* Unemployed and retired individuals
* Individuals with alcohol or drug addiction
* Individuals diagnosed with psychiatric or neurological diseases
* Illiterate individuals.

Primary outcomes:
measure: EAT-Lancet Index score
timeFrame: Baseline
Secondary outcomes:
measure: Behaviors scale towards sustainable nutrition (BSSN) score
timeFrame: Baseline
measure: Sociodemographic characteristics
timeFrame: Baseline
measure: Body Mass Index (BMI)
timeFrame: Baseline
measure: Body weight
timeFrame: Baseline
measure: Height
timeFrame: Baseline
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Ankara Yıldırım Beyazıt University
Study officials:
References:
Clinical trial NCT01441713: Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
Official title: Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Prostatic Neoplasms
Keywords: Hormone treatment
castration
Orchiectomy
treatment frequency
treatment satisfaction
side effects
Lead sponsor: Copenhagen University Hospital at Herlev
Sponsor class: OTHER
First posted: 2011-09-28
Enrollment: 178
Sex: MALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Men who are receiving pharmaceutical castration treatment (hormone treatment) at Herlev Hospital for advanced prostate cancer and men who have undergone surgical castration (Orchiectomy) and are in clinical control at Herlev Hospital.

Brief summary: Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often given with a 3 month interval.

Over the last few years new drugs, which allow for lees frequent treatment, have been developed. The purpose of this study is to assess how the treatment affects patients and if our current patients would prefer to receive treatment at different intervals than they do at the present time. At the same time the investigators will assess how surgical treatment affects our patients. This will be assessed by patient questionnaires administered at our clinic.


Eligibility criteria: Inclusion Criteria:

* A diagnosis of advanced prostate cancer
* Receiving hormone manipulation treatment (pharmaceutical castration) OR having undergone surgical castration (orchiectomy)

Exclusion Criteria:

* Inability to read/write Danish

Primary outcomes:
measure: Preferred treatment/control frequency for patients with advanced prostate cancer
timeFrame: Up to 1 year
Secondary outcomes:
measure: Treatment satisfaction
timeFrame: Up to 1 year
measure: Side effects to treatment
timeFrame: Up to 1 year
measure: Treatment satisfaction, preferred frequency of clinical control, and side effects after surgical castration
timeFrame: Up to 1 year
Other outcomes:
Locations:
city: Herlev
country: Denmark
facility: Department of urology, Herlev Hospital
Study officials:
affiliation: Herlev Hospital, University of Copenhagen
name: Mikkel Fode, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT01896713: The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer
Official title: To Determine if MultiSpectral 3 Tesla MRI Can Provide Added Value in the Detection of Significant Cancers in Patients o n Active Surveillance for Prostate Cancer
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Prostate Cancer
Keywords: Prostate Cancer
MRI
TRUSBx
Lead sponsor: Sunnybrook Health Sciences Centre
Sponsor class: OTHER
Collaborators: name: Philips Healthcare
First posted: 2013-07-11
Enrollment: 81
Sex: MALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: MultiSpectral 3 Tesla MRI (MS3TMRI) can increase the yield of Trans Rectal Ultrasound Biopsy (TRUSBx) to improve identification of patients on active surveillance requiring treatment.

Detailed description: This is a prospective single arm study. 120 patients at risk for significant occult prostate cancer on an active surveillance program will undergo MS3TMRI followed by a standard TRUSBx and additional biopsies guided by the MS3TMRI results. The positive predictive value (PPV) of MS3TMRI-TRUSBx for cancer requiring consideration of therapy will be compared to the PPV of TRUSBx alone. MS3TMRI consists of T2, diffusion-weighted imaging (DWI), dynamic contrast enhanced MRI (DCEMRI), proton MR spectroscopy (MRS) interpreted by a radiologist and by CAD methods validated on whole mount prostate specimens.

Eligibility criteria: Inclusion Criteria:

* Enrolled in active surveillance at Sunnybrook Health Sciences Centre, requiring biopsy as part of surveillance protocol.
* Clinically eligible for radical prostatectomy and willing to undergo surgery
* Clinically eligible for and willing to undergo ultrasound biopsy within 8 weeks of MRI

Exclusion Criteria:

* Claustrophobia
* Contraindication to MRI
* Contraindication to receiving low molecular weight MRI contrast agent
* Prior hormone therapy except 5-alpha reductase inhibitors such as Avodart. FloMax etc
* Clinically suspected or known compromised renal function or calculated estimated Glomerular Filtration Rate (eGFR) \<30ml/min

Primary outcomes:
measure: The Positive Predictive Value (PPV) of MS3TMRI-TRUSBx for detection of a patient with a cancer burden requiring consideration of immediate therapy.
timeFrame: The outcome measure will be evaluated at the time of the results of the TRUSbx which will be approximately 2 weeks after the biopsy
Secondary outcomes:
measure: The number of cores required for diagnosis of prostate cancer for MS3TMRI-TRUSBx versus TRUSBx alone
timeFrame: The outcome measure will be evaluated at the time of the results of the TRUSbx which will be approximately 2 weeks after the biopsy
Other outcomes:
Locations:
city: Toronto
country: Canada
facility: Sunnybrook Health Sciences Centre
state: Ontario
Study officials:
affiliation: Sunnybrook Health Sciences Centre, University of Toronto
name: Masoom Haider, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT01531413: Oxygen Insufflation To Reduce Postoperative Abscess In Laparoscopic Appendectomy
Official title: Single-Blind, Randomized, Controlled Trial of Oxygen Insufflation to Reduce Incidence of Postoperative Abscess in Laparoscopic Appendectomy
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Postoperative Abscess
Lead sponsor: Chang, Steve S., M.D.
Sponsor class: INDIV
Collaborators: name: Santa Barbara Cottage Hospital
First posted: 2012-02-13
Enrollment: 100
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: Oxygen has inherent bactericidal properties. The investigators are testing to see if they can reduce the incidence of postoperative abscesses following laparoscopic appendectomy by insufflating with oxygen at the end of the case.

Detailed description: Intra-abdominal abscess a well-known complication of both open and laparoscopic appendectomy, especially in the setting of perforated and gangrenous appendicitis. The reviewed literature cites an incidence of about 10%. Besides peri-operative antibiotic administration there have been few developments to reduce this inherent risk. Oxygen rich environments are potently bactericidal, and thus it is our hypothesis that establishing an oxygen rich ambience within the abdomen at the conclusion of laparoscopy could curtail bacterial growth and subsequent abscess formation.

In the experimental arm, at the conclusion of all surgical dissection and manipulation, the carbon dioxide insufflate will be exchanged with oxygen to generate a high intra-abdominal concentration. Oxygen will be infused for 15 seconds as CO2 is allowed to escape through the open trocars. In the control arm Co2 will be allowed to escape through the open trocar ports without any oxygen flush. Patients will receive a standardized operation as well as standard post-operative care and follow up.

Eligibility criteria: Inclusion Criteria:

* Nonpregnant adults 18 or older
* Clinical or image proven appendicitis
* Undergoing Laparoscopic Appendectomy

Exclusion Criteria:

* Any pregnant females
* Anyone under the age of 18

Primary outcomes:
measure: Incidence of Postoperative Abscess
timeFrame: 4 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Santa Barbara
country: United States
facility: Santa Barbara Cottage Hospital
state: California
Study officials:
affiliation: Santa Barbara Cottage Hospital
name: Steve S Chang, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT01593813: Repair or Not Repair Pronator Quadratus in the Volar Plating of Distal Radial Fracture Are Functional Outcomes Differ ?
Official title: Repair or Not Repair Pronator Quadratus in the Volar Plating of Distal Radial Fracture-Are Functional Outcomes Differ ?
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Distal Radius Fracture
Keywords: Pronator quadratus
distal radius fracture
volar plating
Lead sponsor: National Taiwan University Hospital
Sponsor class: OTHER
First posted: 2012-05-08
Enrollment: 100
Sex: ALL
Minimum age (years): 20
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: patient with distal radius fracture

Brief summary: The theoretical benefits of the repair of the pronator quadratus include flexor tendon protection, remain of the normal pronation-supination range of motion (ROM) and strength, and keeping the stable DRUJ.

Repair or not repair pronator quadratus in the volar plating of distal radial fracture-Are functional outcomes differ?

Detailed description: In the operation of distal radial fractures, the volar plating techniques become popular. During the surgical approach, the pronator quadratus (PQ) muscle needs split or full-thickness strip to exposure the fracture site and facilitate the instrumentation of the plate. Generally, the PQ would be repaired. Sometimes, the PQ is damaged by the fracture fragment so severely that it is difficult to repair the PQ. However, there is few reviews paper to discuss the consequence of the unrepaired or repaired PQ and the AAOS guideline1 of the treatment of distal radial fracture in 2009 did not even list the management of the PQ. The function of the PQ includes pronation and stability of the distal radial-ulnar joint (DRUJ). According to the study, the elimination of PQ function will cause a significant decrease in pronation torque, which is supposed to affect the function of the wrist in the daily life. The theoretical benefits of the repair of the pronator quadratus include flexor tendon protection3,4, remain of the normal pronation-supination range of motion (ROM) and strength, and keeping the stable DRUJ.

Eligibility criteria: Inclusion Criteria:

* ≧ 20 or ≦ 80-years-old adult patients
* Cooperative to evaluation
* Distal radial fracture, fresh, single fracture
* Volar plating

Exclusion Criteria:

* \< 20 or \> 80-years-old patients
* Uncooperative adult, such as dementia
* Old fracture, more than 1 Week
* Multiple fractures
* Pathological fracture
* Surgery other then volar plating

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
affiliation: Department of Orthopedics of NTUH
name: Jui-sheng Sun, PHD
role: STUDY_CHAIR
References:
Clinical trial NCT05138913: Arthroscopic Treatment Combine With TXA for Elbow Stiffness
Official title: Prospective Randomized Controlled Study on Arthroscopic Treatment Combine With TXA for Elbow Stiffness
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Tranexamic Acid
Elbow Stiffness
Lead sponsor: Beijing Jishuitan Hospital
Sponsor class: OTHER
First posted: 2021-12-01
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study is a prospective randomized controlled study of different arthroscopic treatments for elbow stiffness combined with tranexamic acid(TXA) injection. The patients with stiffness were randomly divided into groups before the operation. After the arthroscopic operation was completed, they were divided into a local TXA injection group and a control group (normal saline) to perform additional operations for reduction of hemorrhage. In different time periods, the quantitative and qualitative indicators including pain, functional score, range of motion, level of Hemoglobin, the circumference of the limb 10cm above and below the elbow, amount of hemorrhage, etc. were compared between groups at the same time period to evaluate the difference in the effect of arthroscopic treatment combined with TXA on the treatment of reduction of hemorrhage. Determine the effectiveness of TXA.


Eligibility criteria: Inclusion Criteria:

Clinically diagnosed patients with elbow stiffness Young and middle-aged patients aged 18 to 60 with failed nonoperated treatment Voluntarily accept randomized controlled grouping, cooperate with treatment and follow up patients No other comorbidities or medical diseases affect the surgical patients -

Exclusion Criteria:

Elderly people older than 60 years old and patients younger than 18 years old With severe comorbidities or medical diseases affect the surgical patients

-

Primary outcomes:
measure: Mayo Elbow Performance Score
timeFrame: baseline-6 months postoperatively
Secondary outcomes:
measure: Visual analogue scale
timeFrame: baseline-6 months postoperatively
measure: Circumference of upper extremity
timeFrame: baseline-6 months postoperatively
measure: change of hemoglobin
timeFrame: baseline-6 months postoperatively
measure: range of motion
timeFrame: baseline-6 months postoperatively
Other outcomes:
Locations:
city: Beijing
country: China
facility: Beijing Jishuitan hospital
state: Beijing
Study officials:
affiliation: Sports Medicine Service, Beijing Jishuitan hospital
name: Yi Lu
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT01665313: Comparison of Attention of Physician After Outpatient Clinic
Official title: Comparison of Performance, Attention, and Emotion of Physician Before and After Outpatient Clinic Session
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Disturbance of Activity and Attention
Keywords: attention
Lead sponsor: Seoul National University Hospital
Sponsor class: OTHER
First posted: 2012-08-15
Enrollment: 46
Sex: ALL
Minimum age (years): 30
Maximum age (years): 59
Standard ages: ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: physicians with outpatient clinic sessions in Seoul National University Hospital

Brief summary: The attention and clinical performance of physician might be decreased after outpatient clinic session compared to those measured before outpatient clinic.

Detailed description: A large body of data shows that fatigue impairs human performance. Additionally, many studies have provided evidence that fatigue can worsen mood, as indicated by increased scores on measures of depression, anxiety, confusion, and anger. In this context, we examined attentional and emotional changes in physicians after they completed an overwhelming outpatient clinic in a university-affiliated tertiary referral hospital in South Korea.

Eligibility criteria: Inclusion Criteria:

* physicians with outpatient clinic sessions in Seoul National University Hospital
* age 30\~59
* internal part or external part

Exclusion Criteria:

* physicians who do not agree to participate in the study
* physicians who are taking drugs known to affect the sleep/wake cycle or daytime alertness
* physicians who have current psychiatric illness or sleep disorder

Primary outcomes:
measure: difference of response time in PVT(Psychomotor vigilance task) before and after outpatient clinic session
timeFrame: change from baseline in response time in PVT after opd session (average 7hours)
Secondary outcomes:
measure: frequency of physician's clinical mistakes during morning and afternoon session in outpatient clinic
timeFrame: for the duration of opd session, average up to 7hours
Other outcomes:
Locations:
city: Seoul
country: Korea, Republic of
facility: Seoul National University Hospital
Study officials:
affiliation: Seoul National University Hospital
name: Jae-Joon Yim, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06386913: Implementation and Evaluation of Measurement-Based Care (MBC) Training
Official title: Implementation and Evaluation of Measurement-Based Care Training
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Healthy
Keywords: Measurement-Based Care Training
Lead sponsor: Carilion Clinic
Sponsor class: OTHER
Collaborators: name: Virginia Polytechnic Institute and State University
First posted: 2024-04-26
Enrollment: 56
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: Clinicians completed pre- and post-training surveys. Patient satisfaction was assessed prior to and after clinician training.
Primary purpose: OTHER

Brief summary: The purpose of this study is to get feedback on a new standardized Measurement-Based Care (MBC) provider training program.

Detailed description: Measurement-Based Care (MBC) is the systematic ongoing collaborative evaluation of patient symptoms and well-being to inform clinical decision-making and behavioral health treatment. In this study, the goal is to receive feedback through surveys with experienced clinicians/practitioners to improve the training program design. Patient Satisfaction Surveys (PSS) were completed prior to and after clinician training. PSS assessed how Patient-Rated Outcome Measures (PROMs) are utilized by their clinicians, communicated during sessions and the ease to which completion is attainable as well as the patients' opinion regarding the use of such measures in treatment.

Eligibility criteria: Inclusion Criteria:

* Mental health providers in Carilion Clinic

Exclusion Criteria:

* None

Primary outcomes:
measure: Digital MBC training rate
timeFrame: 1 year
measure: Assessing feasibility of a novel digital MBC training in mental health providers (FIM)
timeFrame: 1 year
measure: Assessing acceptability of a novel digital MBC training program in mental health providers (AIM)
timeFrame: 1 year
measure: Assessing appropriateness of a novel digital MBC training program in mental health providers (IAM)
timeFrame: 1 year
Secondary outcomes:
Other outcomes:
measure: Monitoring and Feedback Attitudes Scale (MFA)
timeFrame: 1 year
measure: Attitudes Towards Standardized Assessment Scales: Monitoring and Feedback (ASA-MF)
timeFrame: 1 year
measure: Clinician Attitude and Satisfaction Survey (CASS)
timeFrame: 1 year
Locations:
city: Roanoke
country: United States
facility: Carilion Clinic
state: Virginia
Study officials:
affiliation: Carilion Clinic
name: Robert L Trestman, PHD, MD
role: STUDY_DIRECTOR
References: